You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global Cancer Therapeutics And Biotherapeutics Market Size, Status and Forecast 2020-2026

The global cancer therapeutics and biotherapeutics market is drived by the introduction of products such as gemcitabin, oxaliplatin and pemetrexed.
The increasing occurrence of different types of cancer and the increasing proliferation of new players in this market are expected to boost the development of global cancer therapeutics and biotherapeutics market.
Market Analysis and Insights: Global Cancer Therapeutics And Biotherapeutics Market
The global Cancer Therapeutics And Biotherapeutics market size is projected to reach US$ 9118.3 million by 2026, from US$ 8707.3 million in 2020, at a CAGR of 4.4%% during 2021-2026.

Global Cancer Therapeutics And Biotherapeutics Scope and Market Size
Cancer Therapeutics And Biotherapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Therapeutics And Biotherapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Bristol-Myers Squibb
AstraZeneca
Pfizer
Biogen IDEC
Sanofi
Genentech
Novartis
Johnson & Johnson
Roche and Schering-Plough
Cancer Therapeutics And Biotherapeutics Breakdown Data by Type
Chemotherapy
Radiation Therapy
Hormone Therapy
Biotherapy
Cancer Therapeutics And Biotherapeutics Breakdown Data by Application
Consumption (Sales)
Household
Hospital
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Therapeutics And Biotherapeutics Revenue
1.4 Market by Type
1.4.1 Global Cancer Therapeutics And Biotherapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Radiation Therapy
1.4.4 Hormone Therapy
1.4.5 Biotherapy
1.5 Market by Application
1.5.1 Global Cancer Therapeutics And Biotherapeutics Market Share by Application: 2020 VS 2026
1.5.2 Consumption (Sales)
1.5.3 Household
1.5.4 Hospital
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Cancer Therapeutics And Biotherapeutics Market Perspective (2015-2026)
2.2 Global Cancer Therapeutics And Biotherapeutics Growth Trends by Regions
2.2.1 Cancer Therapeutics And Biotherapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Therapeutics And Biotherapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Therapeutics And Biotherapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cancer Therapeutics And Biotherapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Cancer Therapeutics And Biotherapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Cancer Therapeutics And Biotherapeutics Players by Market Size
3.1.1 Global Top Cancer Therapeutics And Biotherapeutics Players by Revenue (2015-2020)
3.1.2 Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Cancer Therapeutics And Biotherapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Therapeutics And Biotherapeutics Market Concentration Ratio
3.2.1 Global Cancer Therapeutics And Biotherapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cancer Therapeutics And Biotherapeutics Revenue in 2019
3.3 Cancer Therapeutics And Biotherapeutics Key Players Head office and Area Served
3.4 Key Players Cancer Therapeutics And Biotherapeutics Product Solution and Service
3.5 Date of Enter into Cancer Therapeutics And Biotherapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Cancer Therapeutics And Biotherapeutics Historic Market Size by Type (2015-2020)
4.2 Global Cancer Therapeutics And Biotherapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020)
5.2 Global Cancer Therapeutics And Biotherapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Cancer Therapeutics And Biotherapeutics Market Size (2015-2020)
6.2 Cancer Therapeutics And Biotherapeutics Key Players in North America (2019-2020)
6.3 North America Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020)
6.4 North America Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Cancer Therapeutics And Biotherapeutics Market Size (2015-2020)
7.2 Cancer Therapeutics And Biotherapeutics Key Players in Europe (2019-2020)
7.3 Europe Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020)
7.4 Europe Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020)

8 China
8.1 China Cancer Therapeutics And Biotherapeutics Market Size (2015-2020)
8.2 Cancer Therapeutics And Biotherapeutics Key Players in China (2019-2020)
8.3 China Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020)
8.4 China Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Cancer Therapeutics And Biotherapeutics Market Size (2015-2020)
9.2 Cancer Therapeutics And Biotherapeutics Key Players in Japan (2019-2020)
9.3 Japan Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020)
9.4 Japan Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size (2015-2020)
10.2 Cancer Therapeutics And Biotherapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020)

11 India
11.1 India Cancer Therapeutics And Biotherapeutics Market Size (2015-2020)
11.2 Cancer Therapeutics And Biotherapeutics Key Players in India (2019-2020)
11.3 India Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020)
11.4 India Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Cancer Therapeutics And Biotherapeutics Market Size (2015-2020)
12.2 Cancer Therapeutics And Biotherapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Therapeutics And Biotherapeutics Market Size by Type (2015-2020)
12.4 Central & South America Cancer Therapeutics And Biotherapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Details
13.1.2 Bristol-Myers Squibb Business Overview
13.1.3 Bristol-Myers Squibb Cancer Therapeutics And Biotherapeutics Introduction
13.1.4 Bristol-Myers Squibb Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020))
13.1.5 Bristol-Myers Squibb Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview
13.2.3 AstraZeneca Cancer Therapeutics And Biotherapeutics Introduction
13.2.4 AstraZeneca Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Cancer Therapeutics And Biotherapeutics Introduction
13.3.4 Pfizer Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Biogen IDEC
13.4.1 Biogen IDEC Company Details
13.4.2 Biogen IDEC Business Overview
13.4.3 Biogen IDEC Cancer Therapeutics And Biotherapeutics Introduction
13.4.4 Biogen IDEC Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020)
13.4.5 Biogen IDEC Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview
13.5.3 Sanofi Cancer Therapeutics And Biotherapeutics Introduction
13.5.4 Sanofi Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 Genentech
13.6.1 Genentech Company Details
13.6.2 Genentech Business Overview
13.6.3 Genentech Cancer Therapeutics And Biotherapeutics Introduction
13.6.4 Genentech Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020)
13.6.5 Genentech Recent Development
13.7 Novartis
13.7.1 Novartis Company Details
13.7.2 Novartis Business Overview
13.7.3 Novartis Cancer Therapeutics And Biotherapeutics Introduction
13.7.4 Novartis Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020)
13.7.5 Novartis Recent Development
13.8 Johnson & Johnson
13.8.1 Johnson & Johnson Company Details
13.8.2 Johnson & Johnson Business Overview
13.8.3 Johnson & Johnson Cancer Therapeutics And Biotherapeutics Introduction
13.8.4 Johnson & Johnson Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020)
13.8.5 Johnson & Johnson Recent Development
13.9 Roche and Schering-Plough
13.9.1 Roche and Schering-Plough Company Details
13.9.2 Roche and Schering-Plough Business Overview
13.9.3 Roche and Schering-Plough Cancer Therapeutics And Biotherapeutics Introduction
13.9.4 Roche and Schering-Plough Revenue in Cancer Therapeutics And Biotherapeutics Business (2015-2020)
13.9.5 Roche and Schering-Plough Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
  • FORMAT: PDF
  • PUBLISHED DATE: Jul, 2020
  • NO OF PAGES: 134